Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Approved for marketing 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 1Diffuse Intrinsic Pontine Glioma 1Brain Neoplasms 1

Interventions

Temozolomide 4vorasidenib 2Lomustine 2Blood Specimen Collection 2trametinib 1tovorafenib 1posaconazole 1perillyl alcohol 1pembrolizumab 1niraparib 1mirdametinib 1gallium maltolate 1dabrafenib 1cemiplimab 1Urination 1Transurethral Resection of Bladder 1Standard of Care 1Spinal Puncture 1Specimen Handling 1Sitagliptin Phosphate 1Receptors, Interleukin-8B 1Radiotherapy 1Radiation 1Positron Emission Tomography Computed Tomography 1Physical Therapy Modalities 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Ketoconazole 1Histocompatibility Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Glioma × tovorafenib × Clear all
NCT07206849 2026-04-08

Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)

Nationwide Children's Hospital

Phase 2 Not yet recruiting
79 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡